A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT06637501 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06637501
- Sponsor
- BeOne Medicines
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-14
- Primary completion
- 2026-11-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.